CTLA4 and autoimmune disease: This induced autoreactive repertoire is similar to those of patients with autoimmune diseases, and autoreactive B cells may induce the development of irAEs frequently associated with anti–CTLA-4 treatment by presenting self antigens through their MHC class II to T cells (9).